市場調査レポート

商品コード

1140011

慢性疾患管理市場：タイプ別、疾患タイプ別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Chronic Disease Management Market By Type, By Disease Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: 2022年07月01日 | 発行: Allied Market Research

| ページ情報: 英文 281 Pages | 納期: 2～3営業日

価格

Cloud Access (Single User License)

USD 3,570 560,989円

レポートのクラウドアクセスでご利用頂けるライセンスです。ウェブポータルで配信され、60日間レポートにアクセスできます。この期間を過ぎるとレポートへのアクセスは失効します。コンテンツのダウンロード、印刷、共有、コピー＆ペーストはできません。

PDF (Business License)

USD 5,820 914,554円

レポートPDFをご利用いただけるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDFl内のテキスト等のコピー＆ペーストは可能です。印刷は5回可能です。追加料金を支払うことで、2～5ユーザーを収容できるようにアップグレードできます。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 9,600 1,508,544円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の慢性疾患管理市場は、2021年に48億9669万米ドル、2031年には148億7548万米ドルに達し、2022年から2031年にかけてCAGRは11.8%で成長すると予測されています。

慢性疾患管理は、スクリーニング、検診、モニタリング、治療の調整、患者教育などを含む、病気を管理するための統合的なケアアプローチです。医療費を削減しながら、生活の質を向上させることができます。慢性疾患管理プログラムは、慢性疾患をより早く、より効果的に発見し治療することにより、慢性疾患を持つ個人の健康を改善し、回避可能な合併症による関連コストを削減し、それらの疾患の進行を遅らせるように設計されています。

市場成長の主な要因は、ヘルスケア・マネジメント・サービスに関する意識の高まりと、がん、心臓病、糖尿病、高血圧などの慢性疾患の有病率の上昇にあります。世界保健機関が発表した報告書によると、2021年には非感染性疾患（NCD）により毎年約4100万人が死亡しており、これは世界全体の死亡者数の71%にあたります。さらに、サービス提供者によるサービスの向上が、市場における慢性疾患管理サービスの需要を高めています。メディカルツーリズム分野の成長とヘルスケアITソリューションの台頭は、慢性疾患管理市場の成長を牽引しています。しかし、熟練した専門家の不足や治療費の高騰、管理システム・ツールへの高い投資が市場の成長を阻害しています。

概要
- 市場規模および予測
循環器系疾患
- 主な市場動向、成長要因、機会
- 市場規模および予測：地域別
- 市場分析：国別
糖尿病分野
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
癌
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
気管支喘息
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
慢性閉塞性肺疾患
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第6章慢性疾患管理市場：エンドユーザー別

概要
- 市場規模・予測
ヘルスケアプロバイダー
- 主な市場動向、成長要因と機会
- 市場規模・予測：地域別
- 市場分析：国別
ヘルスケアペイヤー
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第7章慢性疾患管理市場：地域別

概要
- 市場規模・予測
北米
- 主な動向と機会
- 北米市場規模・予測：タイプ別
- 北米市場規模・予測：疾患タイプ別
- 北米市場規模・予測：エンドユーザー別
- 北米市場規模・予測：国別
  - 米国
  - カナダ
  - メキシコ
欧州
- 主な動向と機会
- 欧州の市場規模・予測：タイプ別
- 欧州市場規模・予測：疾患タイプ別
- 欧州市場規模・予測：エンドユーザー別
- 欧州市場規模・予測：国別
  - ドイツ
  - フランス
  - 英国
  - イタリア
  - スペイン
  - その他の欧州地域
アジア太平洋地域
- 主な動向と機会
- アジア太平洋地域の市場規模・予測：タイプ別
- アジア太平洋地域の市場規模・予測：疾患タイプ別
- アジア太平洋地域の市場規模・予測：エンドユーザー別
- アジア太平洋地域の市場規模・予測：国別
  - 日本
  - 中国
  - オーストラリア
  - インド
  - 韓国
  - その他アジア太平洋地域
LAMEA
- 主な動向と機会
- LAMEAの市場規模・予測：タイプ別
- LAMEAの市場規模・予測：疾患タイプ別
- LAMEAの市場規模・予測：エンドユーザー別
- LAMEAの市場規模・予測：国別
  - ブラジル
  - サウジアラビア
  - 南アフリカ共和国
  - LAMEAの残りの地域

第8章企業情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合のヒートマップ
主な発展

第9章企業プロファイル

Koninklijke Philips N.V
Cognizant TriZetto Software Group Inc,
Cedar Gate Technologies
Casenet, LLC
cliexa, Inc
Altruista Health
Infosys Ltd
Pegasystems Inc
Epic Systems Corporation
Hinduja Global Solutions Ltd
NXGN Management, LLC
ExlServings Holdings, Inc
Vivify Health, Inc
Allscripts Healthcare, LLC
Medecision
ZeOmega
Health Catalyst

図表

LIST OF TABLES

TABLE 1. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 2. CHRONIC DISEASE MANAGEMENT MARKET SIZE, FOR SOLUTIONS, BY REGION, 2021-2031 ($MILLION)
TABLE 3. CHRONIC DISEASE MANAGEMENT MARKET FOR SOLUTIONS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. CHRONIC DISEASE MANAGEMENT MARKET SIZE, FOR SERVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 5. CHRONIC DISEASE MANAGEMENT MARKET FOR SERVICES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 7. CHRONIC DISEASE MANAGEMENT MARKET SIZE, FOR CARDIOVASCULAR DISEASES , BY REGION, 2021-2031 ($MILLION)
TABLE 8. CHRONIC DISEASE MANAGEMENT MARKET FOR CARDIOVASCULAR DISEASES , BY COUNTRY, 2021-2031 ($MILLION)
TABLE 9. CHRONIC DISEASE MANAGEMENT MARKET SIZE, FOR DIABETES, BY REGION, 2021-2031 ($MILLION)
TABLE 10. CHRONIC DISEASE MANAGEMENT MARKET FOR DIABETES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 11. CHRONIC DISEASE MANAGEMENT MARKET SIZE, FOR CANCER, BY REGION, 2021-2031 ($MILLION)
TABLE 12. CHRONIC DISEASE MANAGEMENT MARKET FOR CANCER, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 13. CHRONIC DISEASE MANAGEMENT MARKET SIZE, FOR ASTHMA, BY REGION, 2021-2031 ($MILLION)
TABLE 14. CHRONIC DISEASE MANAGEMENT MARKET FOR ASTHMA, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 15. CHRONIC DISEASE MANAGEMENT MARKET SIZE, FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDERS, BY REGION, 2021-2031 ($MILLION)
TABLE 16. CHRONIC DISEASE MANAGEMENT MARKET FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 17. CHRONIC DISEASE MANAGEMENT MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 18. CHRONIC DISEASE MANAGEMENT MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 19. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 20. CHRONIC DISEASE MANAGEMENT MARKET SIZE, FOR HEALTHCARE PROVIDERS, BY REGION, 2021-2031 ($MILLION)
TABLE 21. CHRONIC DISEASE MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 22. CHRONIC DISEASE MANAGEMENT MARKET SIZE, FOR HEALTHCARE PAYERS, BY REGION, 2021-2031 ($MILLION)
TABLE 23. CHRONIC DISEASE MANAGEMENT MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 24. CHRONIC DISEASE MANAGEMENT MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 25. CHRONIC DISEASE MANAGEMENT MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 26. CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 27. NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 28. NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 29. NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 30. NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 31. U.S. CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 32. U.S. CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 33. U.S. CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 34. CANADA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 35. CANADA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 36. CANADA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 37. MEXICO CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 38. MEXICO CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 39. MEXICO CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 40. EUROPE CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 41. EUROPE CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 42. EUROPE CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 43. EUROPE CHRONIC DISEASE MANAGEMENT MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 44. GERMANY CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 45. GERMANY CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 46. GERMANY CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 47. FRANCE CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 48. FRANCE CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 49. FRANCE CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 50. U.K. CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 51. U.K. CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 52. U.K. CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 53. ITALY CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 54. ITALY CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 55. ITALY CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 56. SPAIN CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 57. SPAIN CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 58. SPAIN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 59. REST OF EUROPE CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 60. REST OF EUROPE CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 61. REST OF EUROPE CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 62. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 63. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 64. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 65. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 66. JAPAN CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 67. JAPAN CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 68. JAPAN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 69. CHINA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 70. CHINA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 71. CHINA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 72. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 73. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 74. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 75. INDIA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 76. INDIA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 77. INDIA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 78. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 79. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 80. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 81. REST OF ASIA PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 82. REST OF ASIA PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 83. REST OF ASIA PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 84. LAMEA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 85. LAMEA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 86. LAMEA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 87. LAMEA CHRONIC DISEASE MANAGEMENT MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 88. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 89. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 90. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 91. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 92. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 93. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 94. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 95. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 96. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 97. REST OF LAMEA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 98. REST OF LAMEA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 99. REST OF LAMEA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 100.KONINKLIJKE PHILIPS N.V: COMPANY SNAPSHOT
TABLE 101.KONINKLIJKE PHILIPS N.V: OPERATING SEGMENTS
TABLE 102.KONINKLIJKE PHILIPS N.V: PRODUCT PORTFOLIO
TABLE 103.KONINKLIJKE PHILIPS N.V: NET SALES,
TABLE 104.KONINKLIJKE PHILIPS N.V: KEY STRATERGIES
TABLE 105.COGNIZANT TRIZETTO SOFTWARE GROUP INC,: COMPANY SNAPSHOT
TABLE 106.COGNIZANT TRIZETTO SOFTWARE GROUP INC,: OPERATING SEGMENTS
TABLE 107.COGNIZANT TRIZETTO SOFTWARE GROUP INC,: PRODUCT PORTFOLIO
TABLE 108.COGNIZANT TRIZETTO SOFTWARE GROUP INC,: NET SALES,
TABLE 109.COGNIZANT TRIZETTO SOFTWARE GROUP INC,: KEY STRATERGIES
TABLE 110.CEDAR GATE TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 111.CEDAR GATE TECHNOLOGIES: OPERATING SEGMENTS
TABLE 112.CEDAR GATE TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 113.CEDAR GATE TECHNOLOGIES: NET SALES,
TABLE 114.CEDAR GATE TECHNOLOGIES: KEY STRATERGIES
TABLE 115.CASENET, LLC: COMPANY SNAPSHOT
TABLE 116.CASENET, LLC: OPERATING SEGMENTS
TABLE 117.CASENET, LLC: PRODUCT PORTFOLIO
TABLE 118.CASENET, LLC: NET SALES,
TABLE 119.CASENET, LLC: KEY STRATERGIES
TABLE 120.CLIEXA, INC: COMPANY SNAPSHOT
TABLE 121.CLIEXA, INC: OPERATING SEGMENTS
TABLE 122.CLIEXA, INC: PRODUCT PORTFOLIO
TABLE 123.CLIEXA, INC: NET SALES,
TABLE 124.CLIEXA, INC: KEY STRATERGIES
TABLE 125.ALTRUISTA HEALTH: COMPANY SNAPSHOT
TABLE 126.ALTRUISTA HEALTH: OPERATING SEGMENTS
TABLE 127.ALTRUISTA HEALTH: PRODUCT PORTFOLIO
TABLE 128.ALTRUISTA HEALTH: NET SALES,
TABLE 129.ALTRUISTA HEALTH: KEY STRATERGIES
TABLE 130.INFOSYS LTD: COMPANY SNAPSHOT
TABLE 131.INFOSYS LTD: OPERATING SEGMENTS
TABLE 132.INFOSYS LTD: PRODUCT PORTFOLIO
TABLE 133.INFOSYS LTD: NET SALES,
TABLE 134.INFOSYS LTD: KEY STRATERGIES
TABLE 135.PEGASYSTEMS INC: COMPANY SNAPSHOT
TABLE 136.PEGASYSTEMS INC: OPERATING SEGMENTS
TABLE 137.PEGASYSTEMS INC: PRODUCT PORTFOLIO
TABLE 138.PEGASYSTEMS INC: NET SALES,
TABLE 139.PEGASYSTEMS INC: KEY STRATERGIES
TABLE 140.EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT
TABLE 141.EPIC SYSTEMS CORPORATION: OPERATING SEGMENTS
TABLE 142.EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
TABLE 143.EPIC SYSTEMS CORPORATION: NET SALES,
TABLE 144.EPIC SYSTEMS CORPORATION: KEY STRATERGIES
TABLE 145.HINDUJA GLOBAL SOLUTIONS LTD: COMPANY SNAPSHOT
TABLE 146.HINDUJA GLOBAL SOLUTIONS LTD: OPERATING SEGMENTS
TABLE 147.HINDUJA GLOBAL SOLUTIONS LTD: PRODUCT PORTFOLIO
TABLE 148.HINDUJA GLOBAL SOLUTIONS LTD: NET SALES,
TABLE 149.HINDUJA GLOBAL SOLUTIONS LTD: KEY STRATERGIES
TABLE 150.NXGN MANAGEMENT, LLC: COMPANY SNAPSHOT
TABLE 151.NXGN MANAGEMENT, LLC: OPERATING SEGMENTS
TABLE 152.NXGN MANAGEMENT, LLC: PRODUCT PORTFOLIO
TABLE 153.NXGN MANAGEMENT, LLC: NET SALES,
TABLE 154.NXGN MANAGEMENT, LLC: KEY STRATERGIES
TABLE 155.EXLSERVINGS HOLDINGS, INC: COMPANY SNAPSHOT
TABLE 156.EXLSERVINGS HOLDINGS, INC: OPERATING SEGMENTS
TABLE 157.EXLSERVINGS HOLDINGS, INC: PRODUCT PORTFOLIO
TABLE 158.EXLSERVINGS HOLDINGS, INC: NET SALES,
TABLE 159.EXLSERVINGS HOLDINGS, INC: KEY STRATERGIES
TABLE 160.VIVIFY HEALTH, INC: COMPANY SNAPSHOT
TABLE 161.VIVIFY HEALTH, INC: OPERATING SEGMENTS
TABLE 162.VIVIFY HEALTH, INC: PRODUCT PORTFOLIO
TABLE 163.VIVIFY HEALTH, INC: NET SALES,
TABLE 164.VIVIFY HEALTH, INC: KEY STRATERGIES
TABLE 165.ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT
TABLE 166.ALLSCRIPTS HEALTHCARE, LLC: OPERATING SEGMENTS
TABLE 167.ALLSCRIPTS HEALTHCARE, LLC: PRODUCT PORTFOLIO
TABLE 168.ALLSCRIPTS HEALTHCARE, LLC: NET SALES,
TABLE 169.ALLSCRIPTS HEALTHCARE, LLC: KEY STRATERGIES
TABLE 170.MEDECISION: COMPANY SNAPSHOT
TABLE 171.MEDECISION: OPERATING SEGMENTS
TABLE 172.MEDECISION: PRODUCT PORTFOLIO
TABLE 173.MEDECISION: NET SALES,
TABLE 174.MEDECISION: KEY STRATERGIES
TABLE 175.ZEOMEGA: COMPANY SNAPSHOT
TABLE 176.ZEOMEGA: OPERATING SEGMENTS
TABLE 177.ZEOMEGA: PRODUCT PORTFOLIO
TABLE 178.ZEOMEGA: NET SALES,
TABLE 179.ZEOMEGA: KEY STRATERGIES
TABLE 180.HEALTH CATALYST: COMPANY SNAPSHOT
TABLE 181.HEALTH CATALYST: OPERATING SEGMENTS
TABLE 182.HEALTH CATALYST: PRODUCT PORTFOLIO
TABLE 183.HEALTH CATALYST: NET SALES,
TABLE 184.HEALTH CATALYST: KEY STRATERGIES

LIST OF FIGURES

FIGURE 1.CHRONIC DISEASE MANAGEMENT MARKET SEGMENTATION
FIGURE 2.CHRONIC DISEASE MANAGEMENT MARKET,2021-2031
FIGURE 3.CHRONIC DISEASE MANAGEMENT MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.CHRONIC DISEASE MANAGEMENT MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.CHRONIC DISEASE MANAGEMENT MARKET,BY TYPE,2021(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SOLUTIONS CHRONIC DISEASE MANAGEMENT MARKET,2021-2031(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SERVICES CHRONIC DISEASE MANAGEMENT MARKET,2021-2031(%)
FIGURE 15.CHRONIC DISEASE MANAGEMENT MARKET,BY DISEASE TYPE,2021(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR DISEASES CHRONIC DISEASE MANAGEMENT MARKET,2021-2031(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF DIABETES CHRONIC DISEASE MANAGEMENT MARKET,2021-2031(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF CANCER CHRONIC DISEASE MANAGEMENT MARKET,2021-2031(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ASTHMA CHRONIC DISEASE MANAGEMENT MARKET,2021-2031(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISORDERS CHRONIC DISEASE MANAGEMENT MARKET,2021-2031(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHERS CHRONIC DISEASE MANAGEMENT MARKET,2021-2031(%)
FIGURE 22.CHRONIC DISEASE MANAGEMENT MARKET,BY END USER,2021(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE PROVIDERS CHRONIC DISEASE MANAGEMENT MARKET,2021-2031(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE PAYERS CHRONIC DISEASE MANAGEMENT MARKET,2021-2031(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHERS CHRONIC DISEASE MANAGEMENT MARKET,2021-2031(%)
FIGURE 26.CHRONIC DISEASE MANAGEMENT MARKET BY REGION,2021
FIGURE 27.U.S. CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 28.CANADA CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 29.MEXICO CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 30.GERMANY CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 31.FRANCE CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 32.U.K. CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 33.ITALY CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 34.SPAIN CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 35.REST OF EUROPE CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 36.JAPAN CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 37.CHINA CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 38.AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 39.INDIA CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 40.SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 41.REST OF ASIA PACIFIC CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 42.BRAZIL CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 43.SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 44.SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 45.REST OF LAMEA CHRONIC DISEASE MANAGEMENT MARKET,2021-2031($MILLION)
FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 49.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 50.COMPETITIVE DASHBOARD
FIGURE 51.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 52.KONINKLIJKE PHILIPS N.V.: NET SALES ,($MILLION)
FIGURE 53.COGNIZANT TRIZETTO SOFTWARE GROUP INC,.: NET SALES ,($MILLION)
FIGURE 54.CEDAR GATE TECHNOLOGIES.: NET SALES ,($MILLION)
FIGURE 55.CASENET, LLC.: NET SALES ,($MILLION)
FIGURE 56.CLIEXA, INC.: NET SALES ,($MILLION)
FIGURE 57.ALTRUISTA HEALTH.: NET SALES ,($MILLION)
FIGURE 58.INFOSYS LTD.: NET SALES ,($MILLION)
FIGURE 59.PEGASYSTEMS INC.: NET SALES ,($MILLION)
FIGURE 60.EPIC SYSTEMS CORPORATION.: NET SALES ,($MILLION)
FIGURE 61.HINDUJA GLOBAL SOLUTIONS LTD.: NET SALES ,($MILLION)
FIGURE 62.NXGN MANAGEMENT, LLC.: NET SALES ,($MILLION)
FIGURE 63.EXLSERVINGS HOLDINGS, INC.: NET SALES ,($MILLION)
FIGURE 64.VIVIFY HEALTH, INC.: NET SALES ,($MILLION)
FIGURE 65.ALLSCRIPTS HEALTHCARE, LLC.: NET SALES ,($MILLION)
FIGURE 66.MEDECISION.: NET SALES ,($MILLION)
FIGURE 67.ZEOMEGA.: NET SALES ,($MILLION)
FIGURE 68.HEALTH CATALYST.: NET SALES ,($MILLION)

Product Code: A12327

The global chronic disease management market was valued at $4,896.69 million in 2021 and is projected to reach $14,875.48 million by 2031, registering a CAGR of 11.8% from 2022 to 2031.

Chronic disease management is an integrated care approach to managing the illness, which includes screenings, check-ups, monitoring and coordinating treatment, and patient education. It can improve the quality of life, while reducing healthcare costs. Chronic disease management programs are designed to improve the health of individuals with chronic conditions and reduce associated costs from avoidable complications by identifying and treating chronic conditions more quickly and more effectively; thus slowing the progression of those diseases.

The key factors that drive the growth of the market are an increase in awareness regarding the healthcare management service and a rise in the prevalence of chronic diseases such as cancer, heart disease, diabetes, high blood pressure, and others. According to a report published by the World Health Organization, in 2021, non-communicable diseases (NCDs) killed around 41 million people each year, which was 71% of all deaths globally. Moreover, improved services by the service provider have increased the demand for chronic disease management services in the market. The growth in the medical tourism sector and the rise in healthcare IT solutions drive the growth of the chronic disease management market. However, a lack of skilled professionals and high cost of treatment, and high investment in the management system/tools hinder the growth of the market.

The chronic disease management market is segmented on the basis of type, disease type, end user, and region. By type, the market is bifurcated into solutions and services. The solution segment is further classified on the basis of an on-premise solution and a cloud-based solution. On the basis of service, the segment is segmented into educational service, implementation service, and consulting service. On the basis of disease type, the segment is divided into cardiovascular disease, diabetes, cancer, asthma, a chronic obstructive pulmonary disorder, and others. On the basis of end-user, the segment is divided into providers, payers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for a majority of the chronic disease management market share in 2021 and is anticipated to remain dominant during the forecast period. The factors, such as favorable regulatory scenario, pressure on healthcare institutions to reduce costs, and rise in trends in healthcare IT, big data and cloud computing, well-established healthcare infrastructure, continuous reforms by governments, and an increase in diseased patient burden are driving the growth of the chronic disease management market in the regions.

For instance, the U.S. government implemented the Affordable Care Act (ACA) for the prevention of diseases and the adoption of healthcare IT. The ACA is expected to boost the growth of the chronic disease management market and create opportunities for population health management service providers to collect and maintain patients' data.

The key players that operate in the chronic disease management market are WellSky, ZeOmega, Health Catalyst, Cedar Gate Technologies, Cognizant, Pegasystems Inc., Epic Systems Corporation, Hinduja Global Solutions Ltd. (Bengaluru), NXGN Management, LLC, MINES & Associates, Inc., Casenet, LLC, ExlServings Holdings, Inc., cliexa., ScienceSoft USA Corporation, Vivify Health, Inc., Allscripts Healthcare, LLC, Infosys Limited, Medecision, IBM, Altruista Health, TCS Healthcare Technologies, and Koninklijke Philips N.V. (Netherlands

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the chronic disease management market analysis from 2021 to 2031 to identify the prevailing chronic disease management market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the chronic disease management market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global chronic disease management market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Disease Type

Cardiovascular diseases
Diabetes
Cancer
Asthma
Chronic obstructive pulmonary disorders
Others

By Type

Solutions
Services

By End User

Healthcare Providers
Healthcare Payers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Italy
- Spain
- Rest of Europe
- Germany
- France
- U.K.
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Koninklijke Philips N.V
- Cognizant TriZetto Software Group Inc,
- Cedar Gate Technologies
- Casenet, LLC
- cliexa, Inc
- Altruista Health
- Infosys Ltd
- Pegasystems Inc
- Epic Systems Corporation
- Hinduja Global Solutions Ltd
- NXGN Management, LLC
- ExlServings Holdings, Inc
- Vivify Health, Inc
- Allscripts Healthcare, LLC
- Medecision
- ZeOmega
- Health Catalyst

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Solutions
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
4.3 Services
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country

CHAPTER 5: CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Cardiovascular diseases
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Diabetes
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Cancer
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
5.5 Asthma
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
5.6 Chronic obstructive pulmonary disorders
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country
5.7 Others
- 5.7.1 Key market trends, growth factors and opportunities
- 5.7.2 Market size and forecast, by region
- 5.7.3 Market analysis by country

CHAPTER 6: CHRONIC DISEASE MANAGEMENT MARKET, BY END USER

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Healthcare Providers
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Healthcare Payers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country

CHAPTER 7: CHRONIC DISEASE MANAGEMENT MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Type
- 7.2.3 North America Market size and forecast, by Disease Type
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Market size and forecast, by Type
  - 7.2.5.1.2 Market size and forecast, by Disease Type
  - 7.2.5.1.3 Market size and forecast, by End User
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Market size and forecast, by Type
  - 7.2.5.2.2 Market size and forecast, by Disease Type
  - 7.2.5.2.3 Market size and forecast, by End User
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Market size and forecast, by Type
  - 7.2.5.3.2 Market size and forecast, by Disease Type
  - 7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Type
- 7.3.3 Europe Market size and forecast, by Disease Type
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Market size and forecast, by Type
  - 7.3.5.1.2 Market size and forecast, by Disease Type
  - 7.3.5.1.3 Market size and forecast, by End User
  - 7.3.5.2 France
  - 7.3.5.2.1 Market size and forecast, by Type
  - 7.3.5.2.2 Market size and forecast, by Disease Type
  - 7.3.5.2.3 Market size and forecast, by End User
  - 7.3.5.3 U.K.
  - 7.3.5.3.1 Market size and forecast, by Type
  - 7.3.5.3.2 Market size and forecast, by Disease Type
  - 7.3.5.3.3 Market size and forecast, by End User
  - 7.3.5.4 Italy
  - 7.3.5.4.1 Market size and forecast, by Type
  - 7.3.5.4.2 Market size and forecast, by Disease Type
  - 7.3.5.4.3 Market size and forecast, by End User
  - 7.3.5.5 Spain
  - 7.3.5.5.1 Market size and forecast, by Type
  - 7.3.5.5.2 Market size and forecast, by Disease Type
  - 7.3.5.5.3 Market size and forecast, by End User
  - 7.3.5.6 Rest of Europe
  - 7.3.5.6.1 Market size and forecast, by Type
  - 7.3.5.6.2 Market size and forecast, by Disease Type
  - 7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Disease Type
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 Japan
  - 7.4.5.1.1 Market size and forecast, by Type
  - 7.4.5.1.2 Market size and forecast, by Disease Type
  - 7.4.5.1.3 Market size and forecast, by End User
  - 7.4.5.2 China
  - 7.4.5.2.1 Market size and forecast, by Type
  - 7.4.5.2.2 Market size and forecast, by Disease Type
  - 7.4.5.2.3 Market size and forecast, by End User
  - 7.4.5.3 Australia
  - 7.4.5.3.1 Market size and forecast, by Type
  - 7.4.5.3.2 Market size and forecast, by Disease Type
  - 7.4.5.3.3 Market size and forecast, by End User
  - 7.4.5.4 India
  - 7.4.5.4.1 Market size and forecast, by Type
  - 7.4.5.4.2 Market size and forecast, by Disease Type
  - 7.4.5.4.3 Market size and forecast, by End User
  - 7.4.5.5 South Korea
  - 7.4.5.5.1 Market size and forecast, by Type
  - 7.4.5.5.2 Market size and forecast, by Disease Type
  - 7.4.5.5.3 Market size and forecast, by End User
  - 7.4.5.6 Rest Of Asia Pacific
  - 7.4.5.6.1 Market size and forecast, by Type
  - 7.4.5.6.2 Market size and forecast, by Disease Type
  - 7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Type
- 7.5.3 LAMEA Market size and forecast, by Disease Type
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Market size and forecast, by Type
  - 7.5.5.1.2 Market size and forecast, by Disease Type
  - 7.5.5.1.3 Market size and forecast, by End User
  - 7.5.5.2 Saudi Arabia
  - 7.5.5.2.1 Market size and forecast, by Type
  - 7.5.5.2.2 Market size and forecast, by Disease Type
  - 7.5.5.2.3 Market size and forecast, by End User
  - 7.5.5.3 South Africa
  - 7.5.5.3.1 Market size and forecast, by Type
  - 7.5.5.3.2 Market size and forecast, by Disease Type
  - 7.5.5.3.3 Market size and forecast, by End User
  - 7.5.5.4 Rest of LAMEA
  - 7.5.5.4.1 Market size and forecast, by Type
  - 7.5.5.4.2 Market size and forecast, by Disease Type
  - 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES

9.1 Koninklijke Philips N.V
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
9.2 Cognizant TriZetto Software Group Inc,
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
9.3 Cedar Gate Technologies
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
9.4 Casenet, LLC
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
9.5 cliexa, Inc
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
9.6 Altruista Health
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
9.7 Infosys Ltd
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
9.8 Pegasystems Inc
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
9.9 Epic Systems Corporation
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
9.10 Hinduja Global Solutions Ltd
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
9.11 NXGN Management, LLC
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments
9.12 ExlServings Holdings, Inc
- 9.12.1 Company overview
- 9.12.2 Company snapshot
- 9.12.3 Operating business segments
- 9.12.4 Product portfolio
- 9.12.5 Business performance
- 9.12.6 Key strategic moves and developments
9.13 Vivify Health, Inc
- 9.13.1 Company overview
- 9.13.2 Company snapshot
- 9.13.3 Operating business segments
- 9.13.4 Product portfolio
- 9.13.5 Business performance
- 9.13.6 Key strategic moves and developments
9.14 Allscripts Healthcare, LLC
- 9.14.1 Company overview
- 9.14.2 Company snapshot
- 9.14.3 Operating business segments
- 9.14.4 Product portfolio
- 9.14.5 Business performance
- 9.14.6 Key strategic moves and developments
9.15 Medecision
- 9.15.1 Company overview
- 9.15.2 Company snapshot
- 9.15.3 Operating business segments
- 9.15.4 Product portfolio
- 9.15.5 Business performance
- 9.15.6 Key strategic moves and developments
9.16 ZeOmega
- 9.16.1 Company overview
- 9.16.2 Company snapshot
- 9.16.3 Operating business segments
- 9.16.4 Product portfolio
- 9.16.5 Business performance
- 9.16.6 Key strategic moves and developments
9.17 Health Catalyst
- 9.17.1 Company overview
- 9.17.2 Company snapshot
- 9.17.3 Operating business segments
- 9.17.4 Product portfolio
- 9.17.5 Business performance
- 9.17.6 Key strategic moves and developments

慢性疾患管理市場：タイプ別、疾患タイプ別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Chronic Disease Management Market By Type, By Disease Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章慢性疾患管理市場：タイプ別

第5章慢性疾患管理市場：疾患タイプ別

第6章慢性疾患管理市場：エンドユーザー別

第7章慢性疾患管理市場：地域別

第8章企業情勢

第9章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE

CHAPTER 5: CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE

CHAPTER 6: CHRONIC DISEASE MANAGEMENT MARKET, BY END USER

CHAPTER 7: CHRONIC DISEASE MANAGEMENT MARKET, BY REGION

CHAPTER 8: COMPANY LANDSCAPE

CHAPTER 9: COMPANY PROFILES

慢性疾患管理市場：タイプ別、疾患タイプ別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Chronic Disease Management Market By Type, By Disease Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

第4章 慢性疾患管理市場：タイプ別

第5章 慢性疾患管理市場：疾患タイプ別

第6章 慢性疾患管理市場：エンドユーザー別

第7章 慢性疾患管理市場：地域別

第8章 企業情勢

第9章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE

CHAPTER 5: CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE

CHAPTER 6: CHRONIC DISEASE MANAGEMENT MARKET, BY END USER

CHAPTER 7: CHRONIC DISEASE MANAGEMENT MARKET, BY REGION

CHAPTER 8: COMPANY LANDSCAPE

CHAPTER 9: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章慢性疾患管理市場：タイプ別

第5章慢性疾患管理市場：疾患タイプ別

第6章慢性疾患管理市場：エンドユーザー別

第7章慢性疾患管理市場：地域別

第8章企業情勢

第9章企業プロファイル